Consequently, expanding treatment with TLR2 and -8 blockade to meningitis patients at the initiation of antibiotic therapy — ideally as quickly as possible upon suspected diagnosis — may be a promising therapeutic approach. The gene discussed is TLR2; the disease is meningitis.